SAR 13.56
(2.26%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -3.03 Million | -72.31 Million | -124.56 Million | -159.39 Million | 18.06 Million | -18.77 Million |
Net Income | 42.29 Million | -68.89 Million | -72.7 Million | -105.97 Million | -39.86 Million | 817.64 Thousand |
Depreciation & Amortization | 2.7 Million | 5.4 Million | 3.68 Million | 1.9 Million | 1.82 Million | 1.37 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -33.08 Million | 6.63 Million | -14.8 Million | -32.52 Million | 55.6 Million | 5.83 Million |
Other non-cash items | -14.94 Million | -15.45 Million | -40.73 Million | -22.79 Million | 492.76 Thousand | -19.59 Million |
Investing Cash Flow | -63.24 Million | 8.35 Million | 72.35 Million | 247.63 Million | -49.45 Million | 86.22 Million |
Investments in PPE | -130.58 Thousand | -3.95 Million | -6.45 Million | -2 Million | -2.54 Million | -1.76 Million |
Acquisitions | 19.7 Thousand | 4850.00 | 4.46 Million | -920.89 Thousand | -1.3 Million | - |
Investment purchases | -247.73 Million | -60.34 Million | -59.85 Million | -43.27 Million | -101.17 Million | -17.46 Million |
Sales/Maturities of investments | 184.92 Million | 94.4 Million | 138.66 Million | 173.6 Million | 42.42 Million | 106.1 Million |
Other Investing Activities | -63.11 Million | -21.75 Million | -4.46 Million | 120.23 Million | 13.14 Million | 86.22 Million |
Financing Cash Flow | -938.58 Thousand | -1.29 Million | -2.91 Million | - | - | -32.75 Million |
Debt repayment | -938.08 Thousand | -1.29 Million | -2.91 Million | - | - | - |
Dividends payments | -500.00 | - | -394.00 | - | - | -17.75 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -938.08 Thousand | -1.29 Million | -2.91 Million | - | - | -32.75 Million |
Accounts receivables | 578.72 Thousand | -9.55 Million | -33.99 Million | 27.97 Million | -11.82 Million | -46.84 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -33.66 Million | 16.19 Million | 19.18 Million | -60.5 Million | 67.43 Million | 12.28 Million |
Cash at beginning of period | 222.96 Million | 288.21 Million | 343.33 Million | 255.1 Million | 286.49 Million | 251.8 Million |
Cash at end of period | 155.74 Million | 222.96 Million | 288.21 Million | 343.33 Million | 255.1 Million | 286.49 Million |
Capital Expenditure | -130.58 Thousand | -3.95 Million | -6.45 Million | -2 Million | -2.54 Million | -1.76 Million |
Effect of forex changes on cash | 12.9 Million | - | - | - | - | - |
Net cash flow / Change in cash | -67.21 Million | -65.25 Million | -55.11 Million | 88.23 Million | -31.39 Million | 34.69 Million |
Free Cash Flow | -3.16 Million | -76.27 Million | -131.01 Million | -161.4 Million | 15.51 Million | -20.54 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 10.5 Million | 7.42 Million | 7.31 Million | 28.19 Million | 18.99 Million | 8.96 Million |
Depreciation & Amortization | 747.21 Thousand | 784.77 Thousand | 946.09 Thousand | 3.97 Million | 959.19 Thousand | 751.63 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -16.44 Million | -8.08 Million | 8.5 Million | -14.82 Million | -4.08 Million | -8.01 Million |
Other non-cash items | -919.81 Thousand | -1.62 Million | -24.78 Million | -12.42 Million | -1.5 Million | -8.81 Million |
Investing Cash Flow | 1.99 Million | 7.06 Million | -8 Million | -63.24 Million | -24.77 Million | -3.2 Million |
Investments in PPE | -508.47 Thousand | -67.61 Thousand | -264 Thousand | -462.81 Thousand | -8130.00 | -185.08 Thousand |
Acquisitions | - | - | 1000.00 | 19.7 Thousand | - | 185.08 Thousand |
Investment purchases | -83.23 Million | -25.2 Million | -35.21 Million | -247.73 Million | -4.5 Million | -4.19 Million |
Sales/Maturities of investments | 85.74 Million | 32.33 Million | 27.47 Million | 184.92 Million | 4.42 Million | 4.17 Million |
Other Investing Activities | -3.34 Million | 7.18 Million | -7.88 Million | -63.11 Million | -24.68 Million | -3.18 Million |
Financing Cash Flow | -146.27 Thousand | -326.15 Thousand | -35.83 Thousand | -938.58 Thousand | -445.92 Thousand | -84.66 Thousand |
Debt repayment | - | -326.15 Thousand | -35.33 Thousand | -938.08 Thousand | -445.92 Thousand | -84.66 Thousand |
Dividends payments | - | - | -500.00 | -500.00 | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -146.27 Thousand | - | -35.33 Thousand | - | -445.92 Thousand | -84.66 Thousand |
Accounts receivables | - | - | - | 578.72 Thousand | - | 255.01 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -16.44 Million | -7.87 Million | -11.57 Million | -33.66 Million | -4.08 Million | -8.26 Million |
Cash at beginning of period | 115.28 Million | 111.64 Million | 194.7 Million | 165.96 Million | 184.55 Million | 194.95 Million |
Cash at end of period | 108.37 Million | 115.28 Million | 111.64 Million | 111.64 Million | 173.7 Million | 184.55 Million |
Capital Expenditure | -508.47 Thousand | -67.61 Thousand | -264 Thousand | -462.81 Thousand | -8130.00 | -185.08 Thousand |
Effect of forex changes on cash | - | - | -65.09 Million | 12.9 Million | - | - |
Net cash flow / Change in cash | -6.91 Million | 3.63 Million | -83.05 Million | -54.31 Million | -10.85 Million | -10.39 Million |
Free Cash Flow | -8.11 Million | -3.13 Million | -10.17 Million | -3.49 Million | 14.36 Million | -7.29 Million |
ALKYLAMINE
COHR
YHNF
SURE
BMA
CIOXY